Concepedia
Statistics
Publications
1
Citations
13
H-Index
Active since
2023
Affiliations
Kyungdong Pharmaceutical (South Korea)(Current)
Jong‐Ha Lim is an author at Kyungdong Pharmaceutical (South Korea) specializing in oncology, medicine, and parp inhibition.
Publications per year
2023–2023
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
Myongjae Lee, In‐Gyu Je, Jeong Eun Kim et al. · Molecular Cancer Therapeutics · 2023 · 13 citations · Full text
Medicine, Oncology, Pharmacology +13
1–1 of 1